SARAJEVO (Bosnia and Herzegovina), September 27 (SeeNews) – Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said on Thursday it will increase its base capital by 2.1 million marka ($1.3 million/1.1 million euro).